Published in
Elsevier, Advances in Medical Sciences, 1(65), p. 12-17, 2020
DOI: 10.1016/j.advms.2019.09.002
Links
Tools
Comparative effectiveness of 8 versus 12 weeks of Ombitasvir/Paritaprevir/ritonavir and Dasabuvir in treatment-naïve patients infected with HCV genotype 1b with non-advanced hepatic fibrosis
Journal article published in 2020 by
Dorota Zarębska-Michaluk 
,
Anna Piekarska,
Jerzy Jaroszewicz,
Jakub Klapaczyński,
Włodzimierz Mazur,
Rafał Krygier,
Teresa Belica-Wdowik,
Barbara Baka-Ćwierz,
Ewa Janczewska ,
Paweł Pabjan,
Beata Dobracka,
Beata Lorenc,
Magdalena Tudrujek-Zdunek,
Krzysztof Tomasiewicz,
Marek Sitko
and other authors.
,
Anna Piekarska,
Jerzy Jaroszewicz,
Jakub Klapaczyński,
Włodzimierz Mazur,
Rafał Krygier,
Teresa Belica-Wdowik,
Barbara Baka-Ćwierz,
Ewa Janczewska ,
Paweł Pabjan,
Beata Dobracka,
Beata Lorenc,
Magdalena Tudrujek-Zdunek,
Krzysztof Tomasiewicz,
Marek Sitko
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 